Trial Profile
A Pilot Study of Ipilimumab in Subjects With Stage IV Melanoma Receiving Palliative Radiation Therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 14 Feb 2020 Status changed from active, no longer recruiting to completed.
- 20 Jan 2017 Planned End Date changed from 1 Jun 2016 to 1 Dec 2018.
- 20 Sep 2016 Status changed from recruiting to active, no longer recruiting.